Compound Detail
CHEMBL5188813
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(=O)O[C@H]1C[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3CC[C@@]2(C)[C@@H]2CC=C(C(C)=O)[C@@H]3[C@@H](O)C[C@@]132
Basic Information
| ChEMBL ID | CHEMBL5188813 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SQAJVCGWBQZBLM-ULZMUMJFSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
442.6
MW (Da)
5.47
ALogP
4
HBA
1
HBD
63.6
PSA (Ų)
0.58
QED
1
Ro5 Violations
2
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 8.89
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MCF7 | IC50 | = | 1.3 | nM | 8.89 | Anticancer activity against human MCF7 cells assessed as inhibition of cell grow... | 33940466 |
| HCT-116 | IC50 | = | 1.7 | nM | 8.77 | Anticancer activity against human HCT-116 cells assessed as inhibition of cell g... | 33940466 |
| HepG2 | IC50 | = | 4.7 | nM | 8.33 | Anticancer activity against human HepG2 cells assessed as inhibition of cell gro... | 33940466 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33940466 | 10.1016/j.ejmech.2021.113491 | HCT-116 | 1 |
| 33940466 | 10.1016/j.ejmech.2021.113491 | HepG2 | 1 |
| 33940466 | 10.1016/j.ejmech.2021.113491 | MCF7 | 1 |
Data from ChEMBL 36 via Core Engine